The second in a line of nanofluidic chips — digital arrays — run on the BioMark system for qPCR analysis is available. Digital arrays have been validated for applications that require absolute counting of target molecules, often within samples as small as a single cell. The method of choice to achieve such quantification is known as digital PCR, which has been too impractical for routine use until now.